From: Usefulness of criteria for intraoperative Management of Postoperative Nausea and Vomiting
Item | Pre-criteria group (n = 193) | Post-criteria group (n = 176) | P |
---|---|---|---|
Age | 46 (23–91) | 46 (18–80) | NSa) |
Apfel simplified score (point) | |||
1 | 15 (7.8) | 10 (5.7) | NSb) |
2 | 53 (27.5) | 75 (42.6) | 0.002b) |
3 | 94 (48.7) | 78 (44.3) | NSb) |
4 | 31 (16.1) | 13 (7.4) | 0.009b) |
Disease | |||
Malignant neoplasm of the ovary | 17 (8.8) | 20 (11.4) | NSb) |
Borderline neoplasm of the ovary | 3 (1.6) | 4 (2.3) | NSc) |
Benign neoplasm of the ovary | 29 (15.0) | 27 (15.3) | NSb) |
Malignant neoplasm of the uterus | 19 (9.8) | 26 (14.8) | NSb) |
Benign neoplasm of the uterus | 80 (41.5) | 65 (36.9) | NSb) |
Malignant neoplasm of the soft tissue and other organs | 4 (2.1) | 3 (1.7) | NSc) |
Non-inflammatory disorders of the female genital tract | 36 (18.7) | 28 (15.9) | NSb) |
Others | 5 (2.6) | 3 (1.7) | NSc) |
Laparoscopic surgeries | 97 (50.3) | 127 (72.2) | < 0.0001b) |
Epidural anesthesia | 62 (32.1) | 42 (23.9) | NSb) |
Volatile anesthetics | 153 (79.3) | 149 (84.7) | NSb) |
TIVA | 41 (21.2) | 27 (15.3) | NSb) |
Operative duration (minutes) | 155 (49–639) | 186 (36–597) | NSa) |
Anesthesia duration (minutes) | 201 (86–698) | 198.5 (67–657) | NSa) |
Number of implemented measuresd) | |||
1 | 43 (22.3) | 29 (16.5) | NSb) |
2 | 75 (38.9) | 97 (55.1) | 0.002b) |
3 | 38 (19.7) | 36 (20.5) | NSb) |
4 | 18 (9.3) | 7 (4.0) | NSb) |
5 | 2 (1.0) | 0 (0) | NSc) |
Antiemetics | |||
Dexamethasone | 130 (67.4) | 152 (86.4) | < 0.0001b) |
Droperidol | 130 (67.4) | 134 (76.1) | NSb) |
Metoclopramide | 32 (16.6) | 14 (8.0) | 0.011b) |
Droperidol (PCA) | 56 (29.0) | 32 (18.2) | 0.014b) |
Dose of antiemetics (mg) | |||
Dexamethasone | 6.6 (0–6.6) | 6.6 (0–6.6) | < 0.0001a) |
Droperidol | 0.75 (0–5.0) | 0.875 (0–2.5) | NSa) |
Metoclopramide | 0 (0–20) | 0 (0–10) | 0.012a) |